DRUGS & SUPPLEMENTS

Decadron con Neomicina Ophthalmic

Name: Decadron con Neomicina Ophthalmic drug & pharmaceuticals. Available Forms, Doses, Prices
Creator: sdrugs.com
Published: 2021-11-11T10:10:10+00:00

How is the drug helping you?

Decadron con Neomicina Ophthalmic uses

Caution
Description
Indications
Dosage and administration
Precautions
Warning
How supplied
Decadron con Neomicina Ophthalmic reviews

NADA 042-633, Approved by the FDA.

1050-0030-01

Dermatologic Solution

CAUTION

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION

Dermatologic Solution Decadron con Neomicina Ophthalmic^® (thiabendazole, Decadron con Neomicina Ophthalmic, neomycin sulfate solution) contains the following active ingredients per mL: 40 mg thiabendazole, 1 mg Decadron con Neomicina Ophthalmic, 3.2 mg neomycin (from neomycin sulfate). Inactive ingredients: glycerin, propylene glycol, purified water, hypophosphorous acid, calcium hypophosphite; about 8.5% ethyl alcohol and about 0.5% benzyl alcohol.

INDICATIONS

Dermatologic Solution Decadron con Neomicina Ophthalmic is indicated as an aid in the treatment of certain bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs and cats. Both acute and chronic forms of these skin disorders respond to treatment with Decadron con Neomicina Ophthalmic. Many forms of dermatosis are caused by bacteria (chiefly Staphylococcus aureus, Proteus vulgaris and Pseudomonas aeruginosa). Moreover, these organisms often act as opportunistic or concurrent pathogens that may complicate already established mycotic skin disorders, or otoacariasis caused by Otodectes cynotis. The principal etiologic agents of dermatomycoses in dogs and cats are species of the genera Microsporum and Trichophyton. The efficacy of neomycin as an antibacterial agent, with activity against both gram-negative and gram-positive pathogens, is well documented. Detailed studies in various laboratories have verified the significant activity thiabendazole displays against the important dermatophytes. Decadron con Neomicina Ophthalmic, a synthetic adrenocorticoid steroid, inhibits the reaction of connective tissue to injury and suppresses the classic inflammatory manifestations of skin disease. The formulation for Decadron con Neomicina Ophthalmic combines these several activities in a complementary form for control of the discomfort and direct treatment of dermatitis and otitis externa produced by the above-mentioned infectious agents.

DOSAGE AND ADMINISTRATION

Prior to the administration of Dermatologic Solution Decadron con Neomicina Ophthalmic, remove the ceruminous, purulent or foreign materials from the ear canal, as well as the crust which may be associated with dermatoses affecting other parts of the body. The design of the container nozzle safely allows partial insertion into the ear canal for ease of administration. The amount to apply and the frequency of treatment are dependent upon the severity and extent of the lesions. Five to 15 drops should be instilled in the ear twice daily. In treating dermatoses affecting other than the ear the surface of the lesions should be well moistened (2 to 4 drops per square inch) with Dermatologic Solution Decadron con Neomicina Ophthalmic twice daily. The volume required will be dependent upon the size of the lesion.

Application of Decadron con Neomicina Ophthalmic should be limited to a period of not longer than one week.

PRECAUTIONS

On rare occasions dogs may be sensitive to neomycin. In these animals, application of the drug will result in erythema of the treated area, which may last 24 to 48 hours. Also, evidence of transient discomfort has been noted in some dogs when the drug was applied to fissured or denuded areas. The expression of pain may last 2 to 5 minutes. Application of Dermatologic Solution Decadron con Neomicina Ophthalmic should be limited to periods not longer than one week.

While systemic side effects are not likely with topically applied corticosteroids, such a possibility should be considered if use of the solution is extensive and prolonged. If signs of salt and water retention or potassium excretion are noticed (increased thirst, weakness, lethargy, oliguria, gastrointestinal disturbances or tachycardia), treatment should be discontinued and appropriate measures taken to correct the electrolyte and fluid imbalance.

Store in a refrigerator 36 - 46°F (2 - 8°C).

WARNING

For topical use in dogs and cats.

Avoid contact with eyes.

Keep this and all drugs out of the reach of children.

The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse effects in users, to obtain an MSDS, or for assistance call 1-888-637-4251.

HOW SUPPLIED

Product 55871 - Dermatologic Solution Decadron con Neomicina Ophthalmic Veterinary is supplied in 7.5 mL and 15 mL dropper bottles, each in 12 bottle boxes.

Marketed by

Merial, Inc.

Duluth, Georgia 30096-4640

Merial is the Animal Health Division of sanofi.

September 2015

Decadron con Neomicina Ophthalmic is a registered trademark of Merial.

Decadron con Neomicina Ophthalmic pharmaceutical active ingredients containing related brand and generic drugs:

Decadron con Neomicina Ophthalmic available forms, composition, doses:

Solution; Ophthalmic; Dexamethasone; Neomycin Sulfate

Decadron con Neomicina Ophthalmic destination | category:

Human:
Ear anti-infectives and antiseptics
Eye anti-infectives and antiseptics
Topical antibiotics used in the treatment of dermatological diseases

Decadron con Neomicina Ophthalmic Anatomical Therapeutic Chemical codes:

S01CA01 - Dexamethasone and antiinfectives
S02CA06 - Dexamethasone and antiinfectives
S03CA01 - Dexamethasone and antiinfectives

Decadron con Neomicina Ophthalmic pharmaceutical companies:

Merck

References

Dailymed."DEXAMETHASONE TABLET [PHYSICIANS TOTAL CARE, INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Dailymed."NEOMYCIN SULFATE TABLET [LANNETT COMPANY, INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Dailymed."DEXAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Decadron con Neomicina Ophthalmic?

Depending on the reaction of the Decadron con Neomicina Ophthalmic after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Decadron con Neomicina Ophthalmic not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Decadron con Neomicina Ophthalmic addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

Review

sdrugs.com conducted a study on Decadron con Neomicina Ophthalmic, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Decadron con Neomicina Ophthalmic consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.